Jazz Pharmaceuticals plc

By person

20 insiders · 9 transactions

34.4×

Renee D. Gala holds 34.4 times base salary in stock. $34.55M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Renee D. Gala last reported holding, valued at $240.94, the price Ordinary Shares was last bought or sold at on the open market here, on 10 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Iannone Robert

EVP, Global Head of R&D & CMO

—

$19.21M (6) scheduled

−$19.21M

65,686

0.1012%

$15.83M

+4.8%

COZADD BRUCE C

Director

—

$1.50M (1) scheduled

−$1.50M

351,875

0.5421%

$84.78M

−17.6%

GALA RENEE D

President & CEO

—

$486.06K (1) scheduled

−$486.06K

143,394

0.2209%

$34.55M

+156.2%

Patil Neena M

EVP & Chief Legal Officer

—

$289.13K (1) scheduled

−$289.13K

47,671

0.0734%

$11.49M

+28.1%

Mulligan Seamus

Director

—

1,286,254

1.98%

$309.91M

+9.4%

Johnson Philip L

EVP & Chief Financial Officer

—

56,431

0.0869%

$13.60M

+97.5%

Pearce Samantha

EVP, Chief Commercial Officer

—

47,131

0.0726%

$11.36M

+90.7%

O'Keefe Kenneth W

Director

—

25,811

0.0398%

$6.22M

+4.4%

Henderson Mary Elizabeth

SVP, Technical Operations

—

23,815

0.0367%

$5.74M

+63.9%

ENRIGHT PATRICK G

Director

—

21,278

0.0328%

$5.13M

−13.8%

McSharry Heather Ann

Director

—

18,199

0.0280%

$4.38M

−3.7%

RIEDEL NORBERT G

Director

—

17,553

0.0270%

$4.23M

+10.0%

ORiordan Anne

Director

—

16,500

0.0254%

$3.98M

+11.5%

Cook Jennifer E.

Director

—

10,736

0.0165%

$2.59M

+17.5%

Smith Mark Douglas

Director

—

9,579

0.0148%

$2.31M

+4.9%

Winningham Rick E

Director

—

9,466

0.0146%

$2.28M

−25.4%

Hamill Laura

Director

—

6,832

0.0105%

$1.65M

+30.6%

Carr Patricia

SVP, Chief Accounting Officer

—

6,512

0.0100%

$1.57M

−5.3%

Kennedy Patrick

Director

—

6,452

0.0099%

$1.55M

+25.2%

LOVE TED W

Director

—

2,389

0.0037%

$575.61K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

300

$252.76

$75.83K

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

9,259

$251.95

$2.33M

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

19,639

$250.60

$4.92M

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

18,113

$250.02

$4.53M

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

11,423

$248.67

$2.84M

Iannone Robert

27 Aug 2026

EVP, Global Head of R&D & CMO

Sold after exercise

18,187

$247.86

$4.51M

Show all 9 transactions →

Jazz Pharmaceuticals plc

By person

Individual transactions

What was left out